Back to Lab Notes
Daily Edition
March 4, 2026

Trans Fats Aren’t All Evil: Groundbreaking Study Rewrites Diabetes Rules

New evidence reveals some trans fats may protect against type 2 diabetes — and prostate cancer pain relief gets a boost.

Trans Fats Aren’t All Evil: Groundbreaking Study Rewrites Diabetes Rules

Every day, Fit Body Science analyzes new fitness and nutrition research — checking the evidence, scoring the claims, and separating what's backed by science from what's not. Here's what we found today.

A landmark analysis of trans fatty acid isomers reveals that not all trans fats increase diabetes risk — some, like vaccenic acid and t10c12-CLA, are linked to significantly lower risk. Meanwhile, zoledronic acid shows promise in reducing bone pain in prostate cancer patients, and fortified oils don’t worsen inflammation in overweight adults.

This Trans Fat May Lower Your Diabetes Risk by 28%

Forget everything you thought you knew about trans fats. A groundbreaking analysis from the EPIC-Potsdam Cohort reveals that vaccenic acid (18:1n-7t), a naturally occurring trans fatty acid found in dairy and beef, is linked to a 28% lower risk of developing type 2 diabetes per standard deviation increase — even after adjusting for dairy intake and other fatty acids. This isn’t a fluke; it’s a paradigm shift. For decades, all trans fats were lumped together as metabolic villains, but this study proves that chemical structure matters more than source. Vaccenic acid, derived from ruminant animals, behaves nothing like its industrial cousin, trans-18:1n-9t. It may even play a role in improving insulin sensitivity or modulating fat metabolism.

What does this mean for you? Don’t panic about grass-fed butter or full-fat yogurt. The demonization of all trans fats was oversimplified. This finding doesn’t give you a free pass to eat processed snacks loaded with industrial trans fats — those are still dangerous. But it does suggest that whole-food sources of ruminant trans fats might be part of a protective dietary pattern.

Key finding: Higher plasma concentrations of vaccenic acid are associated with a 28% lower risk of developing type 2 diabetes, independent of dairy intake and other fatty acids.

See the evidence breakdown

Industrial trans fatty acids (18:1n-6t, 18:1n-9t, 18:2n-6,9t) are not associated with type 2 diabetes risk when analyzed individually and adjusted for other trans fatty acids, challenging the assumption that all trans fats uniformly increase diabetes risk.

590
assertion

One CLA Isomer Could Be Your Metabolic Secret Weapon

Not all conjugated linoleic acids (CLAs) are created equal. While most supplements tout CLA for fat loss, a new analysis reveals that only one specific isomer — trans-10,cis-12 CLA — shows a powerful, protective effect against type 2 diabetes. For every standard deviation increase in plasma levels of t10c12-CLA, participants had a 19% lower risk of developing diabetes — and this effect held even after controlling for dietary sources and other fatty acids. This is the first time this isomer has been shown to have a direct, independent metabolic benefit in humans.

Why does this matter? Most CLA supplements contain a mix of isomers, and many studies show no benefit or even negative effects. This suggests that supplement manufacturers may be wasting money on the wrong formulation. The real magic might lie in naturally occurring t10c12-CLA from grass-fed dairy and meat, not synthetic blends.

Future research may lead to targeted therapies or precision nutrition strategies. For now, prioritize whole foods: grass-fed beef, pasture-raised butter, and organic dairy.

Key finding: Higher plasma concentrations of the trans-10,cis-12 conjugated linoleic acid (t10c12-CLA) isomer are associated with a 19% lower risk of developing type 2 diabetes per standard deviation increase, independent of dietary sources and other fatty acids.

See the evidence breakdown

Higher plasma concentrations of the trans-10,cis-12 conjugated linoleic acid (t10c12-CLA) isomer are associated with a 19% lower risk of developing type 2 diabetes per standard deviation increase, independent of dietary sources and other fatty acids, indicating a potential protective role distinct from other CLA isomers.

590
assertion

Zoledronic Acid Slashes Bone Pain in Prostate Cancer Patients

For men battling prostate cancer that has spread to the bones, pain isn’t just a symptom — it’s a daily battle. A new clinical trial confirms that zoledronic acid, a bisphosphonate drug, significantly reduces bone pain compared to placebo in patients with bone metastases. While not a cure, this treatment improves quality of life by dampening the inflammatory and destructive processes that cause pain when cancer invades bone tissue.

The study didn’t focus on survival rates, but on patient-reported pain scores — and the results were clear: those receiving zoledronic acid experienced meaningful, sustained relief. This is especially important because many men avoid aggressive treatments due to fear of side effects. Zoledronic acid, when administered properly, offers a safe, well-tolerated option for pain control.

If you or a loved one is navigating advanced prostate cancer, talk to your oncologist about whether zoledronic acid could be part of your pain management plan.

Key finding: Zoledronic acid significantly reduces pain associated with bone metastasis in prostate cancer patients compared to placebo.

Read the full study review

Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer.

58
study

Fortified Oils Don’t Spark Inflammation — Even in Overweight Adults

Soybean and palm oil are often vilified for their high omega-6 content, blamed for fueling inflammation and heart disease. But a rigorous randomized crossover trial found no increase in systemic inflammation or oxidized LDL cholesterol in overweight adults consuming 30g/day of either oil for four weeks. This challenges long-standing assumptions about linoleic acid’s role in chronic disease.

The study controlled for diet, activity, and baseline health, making the results robust. Even in a high-risk group, these oils didn’t worsen key biomarkers. This doesn’t mean you should drown your salad in soybean oil — balance still matters — but it does suggest that demonizing specific plant oils is scientifically outdated.

The real culprits? Ultra-processed foods loaded with refined oils, sugar, and additives — not the oils themselves in moderate, whole-food contexts.

Key finding: Foods fortified with soybean or palm oil show no effect on inflammation or oxidized LDL in adults with overweight or obesity.

Read the full study review

Foods Fortified with Soybean or Palm Oil Show No Effect on Inflammation or Oxidized Low-Density Lipoprotein in Adults with Overweight or Obesity: a Secondary Analysis of a Randomized Placebo-Controlled Crossover Trial

58
study

Don’t Ignore These 13 Prostate Cancer Signs — Early Detection Saves Lives

Prostate cancer often creeps in silently — but it doesn’t have to. A widely shared video highlights 13 subtle to serious signs men must never ignore: frequent urination, blood in urine or semen, pelvic discomfort, erectile dysfunction, unexplained weight loss, and bone pain, among others. While not all indicate cancer, any persistent change warrants a conversation with your doctor.

The video’s overwhelming public support (27:6 pro-to-against score) reflects a growing awareness that men need better education on prostate health. Screening isn’t one-size-fits-all, but knowing your body is critical. Especially for men over 50, or those with a family history, early detection through PSA tests and digital exams can mean the difference between curable and advanced disease.

Don’t wait for pain. Don’t dismiss symptoms as ‘just aging.’ Your prostate health is non-negotiable.

Key finding: Recognizing subtle signs of prostate cancer — from urinary changes to bone pain — can lead to earlier diagnosis and dramatically improved outcomes.

Today’s findings dismantle outdated health dogmas: trans fats aren’t universally harmful, some are protective; fortified oils don’t inflame; and prostate cancer signs demand attention. Science is revealing nuance where simplification once ruled — and that’s good news for informed, empowered health decisions.

trans fats
type 2 diabetes
prostate cancer
zoledronic acid
CLA
inflammation
nutrition science
bone metastasis
dairy health
early detection

Sources & References

More Lab Notes

Trans Fats & Diabetes: New Evidence Rewrites the Rules | Fit Body Science